SyntekaBio Statistics

Total Valuation

SyntekaBio has a market cap or net worth of KRW 104.52 billion. The enterprise value is 99.77 billion.

Market Cap	104.52B
Enterprise Value	99.77B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

SyntekaBio has 15.26 million shares outstanding. The number of shares has increased by 6.50% in one year.

Current Share Class	n/a
Shares Outstanding	15.26M
Shares Change (YoY)	+6.50%
Shares Change (QoQ)	-0.12%
Owned by Insiders (%)	17.18%
Owned by Institutions (%)	1.92%
Float	12.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	4.19
P/TBV Ratio	4.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.83
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.15

Financial Position

The company has a current ratio of 0.77, with a Debt / Equity ratio of 0.29.

Current Ratio	0.77
Quick Ratio	0.74
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	-0.45
Interest Coverage	-7.10

Financial Efficiency

Return on equity (ROE) is -25.68% and return on invested capital (ROIC) is -27.20%.

Return on Equity (ROE)	-25.68%
Return on Assets (ROA)	-18.46%
Return on Invested Capital (ROIC)	-27.20%
Return on Capital Employed (ROCE)	-52.05%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	62
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.42% in the last 52 weeks. The beta is 0.43, so SyntekaBio's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-36.42%
50-Day Moving Average	7,122.40
200-Day Moving Average	6,591.98
Relative Strength Index (RSI)	51.69
Average Volume (20 Days)	406,196

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SyntekaBio had revenue of KRW 120.89 million and -7.21 billion in losses. Loss per share was -473.00.

Revenue	120.89M
Gross Profit	116.97M
Operating Income	-14.27B
Pretax Income	-7.21B
Net Income	-7.21B
EBITDA	-12.02B
EBIT	-14.27B
Loss Per Share	-473.00

Full Income Statement

Balance Sheet

The company has 12.07 billion in cash and 7.31 billion in debt, giving a net cash position of 4.75 billion or 311.42 per share.

Cash & Cash Equivalents	12.07B
Total Debt	7.31B
Net Cash	4.75B
Net Cash Per Share	311.42
Equity (Book Value)	24.94B
Book Value Per Share	1,636.73
Working Capital	-3.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.51 billion and capital expenditures -5.71 billion, giving a free cash flow of -16.22 billion.

Operating Cash Flow	-10.51B
Capital Expenditures	-5.71B
Free Cash Flow	-16.22B
FCF Per Share	-1,062.73

Full Cash Flow Statement

Margins

Gross Margin	96.76%
Operating Margin	-11,804.01%
Pretax Margin	-5,966.88%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SyntekaBio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.50%
Shareholder Yield	-6.50%
Earnings Yield	-6.90%
FCF Yield	-15.51%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SyntekaBio has an Altman Z-Score of 0.52. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.52
Piotroski F-Score	n/a